The drug "Omnitus" instruction characterizes as an antitussive agent, which has a pronounced bronchodilating, expectorant and anti-inflammatory effect. The use of this drug can significantly improve blood oxygenation and spirometry. In addition, the product "Omnitus" (the instruction explains this by the action of the active component) has a direct effect on the cough center. If we talk about the main pharmacokinetic characteristics of this bronchodilator and anti-inflammatory drug, then after taking the maximum concentration in the plasma in two to seven hours (depending on the dosage), and the elimination half-life is about six to ten hours.
The antitussive drug "Omnitus" is issued (the instruction to it confirms it) in the form of biconvex tablets of yellow-orange and red color, and also in the form of a transparent syrup having a characteristic smell of vanilla. The composition of the first as the main component may include 20 or 50 mg of butyrate citrate.
In the role of additional elements are hypromellose, macrogol, lactose monohydrate, black dye, silicon dioxide, talc, povidone, magnesium stearate, ethyl cellulose, titanium dioxide, azorubin dye, and yellow, crimson or brown dye. Cough syrup "Omnitus" contains 0.8 mg of butyrate citrate, 70% sorbitol, sodium saccharinate, vanillin, 96% ethanol, benzoic acid, sodium hydroxide and anise oil. In a small amount, it contains glycerol and purified water.
Use the expectorant and bronchodilator medication "Omnitus" instruction advises to eliminate dry cough of any etiology. For example, this anti-inflammatory agent very well and quickly helps with influenza, pertussis and a variety of cold infections. In addition, this antitussive drug is actively prescribed to suppress cough during bronchoscopy, surgical interventions, as well as in the preoperative and postoperative periods.
To use this anti-inflammatory agent, the manufacturer strongly disagrees with the patient's detection of an allergic reaction to citrate butamate, and also with increased sensitivity to any of the auxiliary components present in its composition. Women who have a baby, should refuse to take an antitussive drug "Omnitus." These tablets should not also be taken during the feeding of the newborn baby with the breast. And, finally, it is not allowed to prescribe this bronchodilator for small patients - children under the age of three.
If you consider the main side effects that can be triggered by taking the drug "Omnitus", then first of all it is necessary to allocate a rather high risk of diarrhea, nausea and exanthema. There may be dizziness, skin flushing, rash, itching and hives.